You are here: Home » International » News » Others
Business Standard

Pfizer Covid-19 vaccine 'very promising' but has cold chain issues: WHO

WHO Director-General Tedros Adhanom Ghebreyesus reiterated the United Nations agency's call for an equitable distribution of vaccine doses once they are available

Topics
Pfizer | World Health Organization | Coronavirus Vaccine

Reuters  |  Geneva 

WHO chief Tedros Adhanom Ghebreyesus | Photo: Twitter/ DrTedros
WHO chief Tedros Adhanom Ghebreyesus | Photo: Twitter/ DrTedros

The World Health Organization's (WHO) chief said on Tuesday it hopes to have a Covid-19 vaccine by year-end and that Pfizer's experimental remedy is "a very promising one", with more expected.

But the vaccine, based on a novel technology that uses synthetic mRNA to activate the immune system against the virus, comes with special challenges as it needs to be stored at minus 70 degrees Celsius (-94 F) or below - equivalent to an Antarctic winter.

WHO Director-General Tedros Adhanom Ghebreyesus reiterated the United Nations agency's call for an equitable distribution of vaccine doses once they are available.

said on Monday that its Covid-19 vaccine was more than 90% effective as it disclosed the first successful interim data from a large-scale clinical test. The safety data on its vaccine with BioNTech SE could come later this month."As we have been predicting, we will have a vaccine at the end of this year. And the one is a very promising one," Tedros told the WHO's annual ministerial meeting."And we will also expect more and more," he added.

However, the necessity to keep the vaccine in extremely cold storage could complicate any inoculation programme, above all in regions of Asia or Africa where the climate is warm, distances vast and the required infrastructure may be lacking.

"The exciting news yesterday (Monday) of a possible effective vaccine becoming available presages significant challenges for African countries by the type of vaccine that that is. Which will need to be factored into the support to be provided," Matshidiso Moeti, WHO's regional director for Africa, told the ministerial meeting.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, November 10 2020. 23:26 IST
RECOMMENDED FOR YOU
.